SEC Form 4 · accession 0000919574-18-008175

NOVELION THERAPEUTICS INC. · NVLN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

10% Owner

10% Owner

10% Owner

Period of report

Dec 24, 2018

Accepted (ET)

Dec 27, 2018 · 5:34 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000827809

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Shares, without par value^F1	Dec 24, 2018	S	400	$0.98	D	1,948,154	D
Common Shares, without par value^F1	Dec 26, 2018	S	1,200	$0.9325	D	1,946,954	D
Common Shares, without par value^F1	Dec 26, 2018	S	83,245	$0.9784	D	1,863,709	D
Common Shares, without par value^F1	Dec 26, 2018	S	12,450	$0.9078	D	1,851,259	D
Common Shares, without par value^F1	Dec 26, 2018	S	109,900	$0.872	D	1,741,359	D
Common Shares, without par value^F1	Dec 26, 2018	S	12,219	$0.9091	D	1,729,140	D
Common Shares, without par value^F1	Dec 26, 2018	S	28,745	$0.9058	D	1,700,395	D
Common Shares, without par value^F1	Dec 26, 2018	S	30,726	$0.907	D	1,669,669	D
Common Shares, without par value^F1	Dec 27, 2018	S	14,800	$0.8803	D	1,654,869	D
Common Shares, without par value^F1	Dec 27, 2018	S	56,316	$0.8548	D	1,598,553	D
Common Shares, without par value^F1	Dec 27, 2018	S	100,000	$0.8514	D	1,498,553	D

No Table II lines on this filing.

F1The Common Stock is held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.